Johnson & Johnson has come out with a new drug, called Yondelis, to treat certain kind of soft tissue sarcomas.
USFDA recently approved this drug for treatment of such soft tissue sarcomas which cannot be surgically removed, or have spread to other body parts.
Intended to treat Liposarcoma and Leiomyosarcoma, which is fat cell and smooth muscle sarcomas respectively, this is the first US drug to be approved for the fatty tissue sarcoma.
